Subscribe   RSS Contact Us

Sen. John Barrasso Invited to Speak at CHC Member Meeting in D.C.

Sept. 23, 2016 – Sen. John Barrasso (R-Wyo.) has been invited to speak at the Coalition for Healthcare Communication Member ... read more

OPDP’s Second Enforcement Letter in Two Weeks Targets Investigational Drug

Sept. 15, 2016 – Although the FDA’s Office of Prescription Drug Promotion (OPDP) has only issued four enforcement letters this ... read more

OPDP Sends Enforcement Letter for Promotion of Investigational Drug

Sept. 8, 2016 — The FDA’s Office of Prescription Drug Promotion (OPDP) takes issue with a conference panel for an ... read more

FDA to Hold Post-election Hearing on Off-label Communication

Sept. 1, 2016 – In the wake of the agency’s recent settlement with Amarin and other rulings that support the ... read more

FDA May Still Issue Four Advertising Guidances in 2016

Aug. 11, 2016 — The FDA announced Aug. 10 that it plans to issue four, much-awaited advertising-related guidance documents before ... read more

Study Shows ACA Increases Use of Rx Drugs, Decreases Out-of-pocket Spending

Aug. 19, 2016 – The Affordable Care Act (ACA) has resulted in increases in the use of prescription drugs and ... read more

Gender and Healthcare Communications

By Nick Colucci, Publicis Health CEO July 21, 2016 — I was moved by a recent op-ed in The New ... read more

Medical Associations Support Bill Exempting Journals and Textbooks from Sunshine Reporting

July 15, 2016 – More than 100 medical associations, including the American Medical Association, signed a letter of support for ... read more

Pfizer Gets in Front of Opioid Marketing Issue

July 8, 2016 – As organized medicine, politicians and the public seek to reverse the scourge of opioid addiction, Pfizer ... read more

CEOs to Coalition’s Rising Leaders: Engage in Political Process, Keep Learning

June 17, 2016 – In order to stay ahead of change, further their careers and forward the positive message of ... read more

Davidson Sums Up Past and Current State of DTC Ad Restrictions, Ad Tax Deduction

June 7, 2016 – The Advertising Coalition (TAC) Executive Director Jim Davidson gave industry’s next generation a comprehensive overview of ... read more

Congressman Jenkins to Coalition’s Rising Leaders: You Have the Power to Influence Lawmakers

May 24, 2016 – At a recent Coalition for Healthcare Communication Rising Leaders Conference, keynote speaker Rep. Evan Jenkins (R-W. ... read more

NYTimes: Ban on Drug Ads Would Also Eliminate Ad Benefits

March 14, 2016 — The American Medical Association (AMA) as well as Rep. Rosa DeLauro (D-Conn.) and Sen. Al Franken ... read more

CHC and CCC Launching Regulatory Compliance University for Agencies, Publishers

Aug. 19, 2015 – The Coalition for Healthcare Communication (CHC) is partnering with the Center for Communication Compliance (CCC) to ... read more

Author of “Pharmaphobia” Says Conflict-of-interest Regulations Are Slowing Medical Progress

June 8, 2015 – In his new book, “Pharmaphobia: How the Conflict of Interest Myth Undermines American Medical Innovation,” Tom ... read more

Previous Next

Coalition and Med Ad News Present Healthcare Podcasts

You can visit to download podcasts on healthcare issues by John Kamp, the Coalition”s Executive Director.

persuasive essay writing

The 1st is on the defeated but still looming ad tax bill. The 2nd is an overview and analysis of the “New FDA.”

Med Ad News plans to present 3 more podcasts in this series.bayer cipro prostatitis

Study Finds CME Funding Doesn’t Create Bias

A new study by 4 researchers from the Cleveland Clinic showed that industry support of continuing medical education created no bias among participants.

The study acknowledges the controversy surrounding CME funding, then explains how it tested for bias among its participants. It is important to note that no previously published studies have addressed this perceived bias.

Peter Pitts Tells Why FDA DDMAC Letter to Bauman Isn’t a First Amendment Issue

From :

Much brouhaha about the DDMAC letter sent to Dr. Leslie Bauman about her enthusiastic comments about a yet-to-be-approved anti wrinkle injectable.

At first blush, this seems like regulatory creep and cause for First Amendment agita. But it isn”t. This is not a case of the FDA trying to stifle unregulated speech by an individual without “interest.” Dr. Bauman is a clinical And if you need to relax and unwind a little, what can be better than playing a fun game, which will not set your bank account short? Here on Slotozilla, you can play free slot machines any time of day, with no breaks and no curfews. investigator for the product she”s been touting. That”s “interest” whether the trial sponsor paid her to do so or not. (In this instance, there was no “pay for play.”) In any case, it”s an unambiguous regulatory no-no.

descriptive essay

Your comments are welcome here.internet viagra pharmacy

MM&M Profiles Tom Sullivan, a Forceful Defender of CME

The February issue of MM&M magazine spotlights Policymed.com blogger Tom Sullivan.

personal essay definition

Read the articleviagra, candadian drugs